Skip to main content
. 2017 Nov 8;15(2):138–145. doi: 10.1177/1479972317736293

Table 1.

Comparison of baseline characteristics between never-smokers without COPD and those with COPD.a

Total (n = 131) Never-smokers without COPD (n = 54; 41.2%) Never-smokers with COPD (n = 77; 58.8%) p
Age 73.0 (70.0, 77.0) 73.0 (69.0, 77.0) 74.0 (71.0, 78.0) 0.314
Female 95 (72.5) 38 (70.4) 57 (74.0) 0.793
BMI (kg m−2) 24.0 ± 3.1 23.9 ± 3.2 24.1 ± 3.1 0.682
Extra-pulmonary comorbidities
 Diabetes mellitus 16 (12.2) 7 (13.0) 9 (11.7) 1.0
 Cerebrovascular disease 12 (9.2) 5 (9.3) 7 (9.1) 1.0
 Malignancy 6 (4.6) 3 (5.6) 3 (3.9) 0.976
 Chronic liver disease 5 (3.8) 2 (3.7) 3 (3.9) 1.0
 Chronic kidney disease 3 (2.3) 2 (3.7) 1 (1.3) 0.772
Pulmonary comorbidities
 Asthma 30 (22.9) 11 (20.4) 19 (24.7) 0.575
 Bronchiectasis 4 (3.1) 1 (1.9) 3 (3.9) 0.782
CAT score 18.0 (9.0, 26.0) 18.0 (9.0, 24.0) 19.0 (8.0, 26.0) 0.830
mMRC dyspnea scale 0.536
 0 25 (19.1) 13 (24.1) 12 (15.6)
 1 56 (42.8) 22 (40.7) 34 (44.1)
 2 16 (12.2) 8 (14.8) 8 (10.4)
 3 26 (19.8) 9 (16.7) 17 (22.1)
 4 8 (6.1) 2 (3.7) 6 (7.8)
Severity of airflow limitations <0.001
 Mild 46 (35.1) 46 (59.7)
 Moderate 30 (22.9) 30 (39.0)
 Severe 1 (0.8) 1 (1.3)
Post-BD spirometry
 FVC (L) 2.6 (2.1, 3.1) 2.7 (2.2, 3.1) 2.4 (2.1, 3.4) 0.510
 FVC (% predicted) 103.0 (93.5, 114.0) 100.5 (93.0, 113.0) 104.0 (94.0, 115.0) 0.583
 FEV1 (L) 1.7 (1.4, 2.1) 2.1 (1.7, 2.3) 1.5 (1.2, 1.9) <0.001
 FEV1 (% predicted) 94.0 (80.6, 104.5) 99.5 (94.0, 115.0) 86.0 (72.0, 96.0) <0.001
 FEV1/FVC (%) 66.7 ± 9.4 75.5 ± 3.7 60.6 ± 6.6 <0.001

COPD: chronic obstructive pulmonary disease; BMI: body mass index; mMRC: modified Medical Research Council; BD: bronchodilator; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; CAT: COPD assessment test.

aCategorical variables are presented as number (%) and continuous variables are presented as mean and standard deviation or median and interquartile range, as appropriate.